Beta-Amyloid Peptides Enhance the Proliferative Response of Activated CD4+CD28+ Lymphocytes from Alzheimer Disease Patients and from Healthy Elderly
Reads0
Chats0
TLDR
It is suggested that the effect of Aβ peptides on the immune system of AD patients does not depend on the specific reactivity to Aβ epitope(s), but is rather a consequence of an unspecific modulation of the cell cycle dynamics and cytokine production by T cells, occurring simultaneously in a huge proportion of A β peptide-exposed T lymphocytes and affecting theimmune system performance.Abstract:
Alzheimer's disease (AD) is the most frequent form of dementia among elderly. Despite the vast amount of literature on non-specific immune mechanisms in AD there is still little information about the potential antigen-specific immune response in this pathology. It is known that early stages of AD include β-amyloid (Aβ)- reactive antibodies production and inflammatory response. Despite some evidence gathered proving cellular immune response background in AD pathology, the specific reactions of CD4+ and CD8+ cells remain unknown as the previous investigations yielded conflicting results. Here we investigated the CD4+CD28+ population of human peripheral blood T cells and showed that soluble β-amyloids alone were unable to stimulate these cells to proliferate significantly, resulting only in minor, probably antigen-specific, proliferative response. On the other hand, the exposure of in vitro pre-stimulated lymphocytes to soluble Aβ peptides significantly enhanced the proliferative response of these cells which had also lead to increased levels of TNF, IL-10 and IL-6. We also proved that Aβ peptide-enhanced proliferative response of CD4+CD28+ cells is autonomous and independent from disease status while being associated with the initial, ex vivo activation status of the CD4+ cells. In conclusion, we suggest that the effect of Aβ peptides on the immune system of AD patients does not depend on the specific reactivity to Aβ epitope(s), but is rather a consequence of an unspecific modulation of the cell cycle dynamics and cytokine production by T cells, occurring simultaneously in a huge proportion of Aβ peptide-exposed T lymphocytes and affecting the immune system performance.read more
Citations
More filters
Journal ArticleDOI
Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease
Gero Lueg,Catharina C. Gross,Hubertus Lohmann,Andreas Johnen,André Kemmling,Michael Deppe,Julia Groger,Jens Minnerup,Heinz Wiendl,Sven G. Meuth,Thomas Duning +10 more
TL;DR: In this article, the authors identify a particular immune profile in the peripheral blood (PB) and cerebrospinal fluid (CSF) in patients with mild Alzheimer's disease (mAD) and mild cognitive impairment (MCI) and its potential functional relevance and association with neurodegeneration.
Journal ArticleDOI
Role of the peripheral innate immune system in the development of Alzheimer's disease.
Aurélie Le Page,Gilles Dupuis,Eric Frost,Anis Larbi,Graham Pawelec,Jacek M. Witkowski,Tamas Fulop +6 more
TL;DR: The activation status of peripheral innate immune cells may represent an early biomarker of the upcoming impact on the brain of Alzheimer's disease, and the modulation of these cells may become a useful mechanism for modifying disease progression.
Journal ArticleDOI
Immunosenescence, inflammation and Alzheimer’s disease
Adriana Martorana,Matteo Bulati,Silvio Buffa,Mariavaleria Pellicanò,Calogero Caruso,Giuseppina Candore,Giuseppina Colonna-Romano +6 more
TL;DR: Data is reviewed focusing on changes of some immunoinflammatory parameters observed in patients affected by Alzheimer’s disease to help explain the inflammation commonly present in many age-associated diseases.
Journal ArticleDOI
Aging enhances release of exosomal cytokine mRNAs by Aβ1-42-stimulated macrophages
Masato Mitsuhashi,Dennis D. Taub,Dimitrios Kapogiannis,Erez Eitan,Linda Zukley,Mark P. Mattson,Luigi Ferrucci,Janice B. Schwartz,Edward J. Goetzl +8 more
TL;DR: An Aβ level relevant to neurodegeneration elicited broad M cytokine and ex‐mRNA responses that were significantly greater in the old subjects, but only narrow and age‐independent CD4‐Tm responses.
Journal ArticleDOI
Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer’s disease lacking functional B and T cells
Claudia Späni,Claudia Späni,Tobias Suter,Tobias Suter,Rebecca Derungs,Rebecca Derungs,Maria Teresa Ferretti,Maria Teresa Ferretti,Tobias Welt,Fabian Wirth,Fabian Wirth,Christoph Gericke,Christoph Gericke,Roger M. Nitsch,Roger M. Nitsch,Luka Kulic,Luka Kulic +16 more
TL;DR: An impact of the adaptive immunity on cerebral β-amyloid pathology in vivo is demonstrated and an influence on microglia-mediated amyloid β-peptide clearance as a possible underlying mechanism is suggested.
References
More filters
Journal ArticleDOI
Inflammation and Alzheimer's disease.
Haruhiko Akiyama,Steven W. Barger,Scott R. Barnum,B Bradt,Jürgen Bauer,Greg M. Cole,Neil R. Cooper,Piet Eikelenboom,Mark R. Emmerling,Bernd L. Fiebich,Caleb E. Finch,Sally A. Frautschy,W. S. T. Griffin,Harald Hampel,Michael Hüll,Gary E. Landreth,Lih-Fen Lue,Robert E. Mrak,Ian R. A. Mackenzie,Patrick L. McGeer,M K O'Banion,Joel S. Pachter,Giulio Maria Pasinetti,C Plata-Salaman,Joseph G. Rogers,Russell E. Rydel,Yueyang Shen,Wolfgang J. Streit,Ronald Strohmeyer,I Tooyoma,F L van Muiswinkel,R. Veerhuis,David G. Walker,Scott D. Webster,Beatrice Hauss–Wegrzyniak,Gary L. Wenk,Tony Wyss-Coray +36 more
TL;DR: By better understanding AD inflammatory and immunoregulatory processes, it should be possible to develop anti-inflammatory approaches that may not cure AD but will likely help slow the progression or delay the onset of this devastating disorder.
Journal ArticleDOI
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Bruno Dubois,Howard Feldman,Claudia Jacova,Steven T. DeKosky,Pascale Barberger-Gateau,Jeffrey L. Cummings,André Delacourte,Douglas Galasko,Serge Gauthier,Gregory A. Jicha,Kenichi Meguro,John T. O'Brien,Florence Pasquier,Philippe Robert,Martin N. Rossor,Steven Salloway,Yaakov Stern,Pieter Jelle Visser,Philip Scheltens +18 more
TL;DR: The NINCDS-ADRDA and DSM-IV-TR criteria for Alzheimer's disease (AD) are the prevailing diagnostic standards in research; however, they have now fallen behind the unprecedented growth of scientific knowledge as discussed by the authors.
Journal ArticleDOI
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
Dale Schenk,Robin Barbour,Whitney Dunn,Grace Gordon,Henry Grajeda,Teresa Guido,Kang Hu,Jiping Huang,Kelly Johnson-Wood,Karen Khan,Dora Kholodenko,Michael K. Lee,Zhenmei Liao,Ivan Lieberburg,Ruth Motter,Linda Mutter,Ferdie Soriano,George Shopp,Vasquez Nicki J,Christopher Vandevert,Shannan Walker,Mark Wogulis,Ted Yednock,Dora Games,Peter Seubert +24 more
TL;DR: It is reported that immunization of the young animals essentially prevented the development of β-amyloid-plaque formation, neuritic dystrophy and astrogliosis, and treatment of the older animals markedly reduced the extent and progression of these AD-like neuropathologies.
Journal ArticleDOI
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
Dave Morgan,David M. Diamond,Paul E. Gottschall,Kenneth E. Ugen,Chad A. Dickey,John Hardy,Karen Duff,Paul T. Jantzen,Giovanni DiCarlo,Donna M. Wilcock,Karen E. Connor,Jaime M. Hatcher,Caroline Hope,Marcia N. Gordon,Gary W. Arendash +14 more
TL;DR: It is shown that vaccination with Aβ protects transgenic mice from the learning and age-related memory deficits that normally occur in this mouse model for Alzheimer's disease and may prevent and, possibly, treat Alzheimer's dementia.
Journal ArticleDOI
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Christopher Janus,Jacqueline Pearson,JoAnne McLaurin,Paul M. Mathews,Ying Jiang,Stephen D. Schmidt,M. Azhar Chishti,Patrick Horne,Donna Heslin,Janet French,Howard T.J. Mount,Ralph A. Nixon,Marc Mercken,Catherine Bergeron,Catherine Bergeron,Paul E. Fraser,Peter St George-Hyslop,Peter St George-Hyslop,David Westaway +18 more
TL;DR: Aβ immunization reduces both deposition of cerebral fibrillar Aβ and cognitive dysfunction in the TgCRND8 murine model of Alzheimer's disease without, however, altering total levels of Aβ in the brain, which implies that either a ∼50% reduction in dense-cored Aβ plaques is sufficient to affect cognition, or that vaccination may modulate the activity/abundance of a small subpopulation of especially toxic Aβ species.